市場調査レポート

商品コード

1319058

過活動膀胱治療薬市場：薬物療法、疾患タイプ、流通別-2023-2030年の世界予測

Overactive Bladder Treatment Market by Drug Therapy, Disease Type, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 746,257円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 903,397円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,060,537円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,374,817円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

過活動膀胱治療薬の世界市場は、2023年に45億4,785万米ドル、CAGR 3.72%で大きく成長し、2030年には58億8,328万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の過活動膀胱治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.過活動膀胱治療薬の世界市場規模および予測は？

2.予測期間中、世界の過活動膀胱治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.過活動膀胱治療薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.過活動膀胱治療薬の世界市場における競争戦略は？

5.過活動膀胱治療薬の世界市場における技術動向と規制の枠組みは？

6.過活動膀胱治療薬の世界市場における主要ベンダーの市場シェアは？

7.過活動膀胱治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 過活動膀胱（OAB）の症状を持つ人の数の増加
  - 高齢化人口の増加
- 抑制要因
  - 過活動膀胱治療薬に関連する悪影響とリスク
- 機会
  - 過活動膀胱の臨床調査試験とパイプライン
- 課題
  - OAB状態の認識が限定的
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章過活動膀胱治療薬市場薬物療法別

抗コリン作用
ボート
ダリフェナシン
フェソテロジン
ミラベグロン
神経刺激
オキシブチニン
ソリフェナシン

第7章過活動膀胱治療薬市場：疾患タイプ別

特発性膀胱過活動
神経因性膀胱過活動

第8章過活動膀胱治療薬市場配信別

病院と病院の薬局
オンライン薬局
小売薬局

第9章南北アメリカの過活動膀胱治療薬市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の過活動膀胱治療薬市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの過活動膀胱治療薬市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. OVERACTIVE BLADDER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2022 VS 2030 (%)
FIGURE 5. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
FIGURE 6. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 7. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. OVERACTIVE BLADDER TREATMENT MARKET DYNAMICS
FIGURE 9. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. OVERACTIVE BLADDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. OVERACTIVE BLADDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. OVERACTIVE BLADDER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 5. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 14. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 17. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 30. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 31. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 34. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 48. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 50. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 51. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 57. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 75. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 88. EGYPT OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 91. FINLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 94. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 102. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 103. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 112. NORWAY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 114. POLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 115. POLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 117. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 118. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 130. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 139. TURKEY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 147. OVERACTIVE BLADDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 148. OVERACTIVE BLADDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 149. OVERACTIVE BLADDER TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-036C5CF3B4EE

The Global Overactive Bladder Treatment Market is forecasted to grow significantly, with a projected USD 4,547.85 million in 2023 at a CAGR of 3.72% and expected to reach a staggering USD 5,883.28 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Overactive Bladder Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Overactive Bladder Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Therapy, market is studied across Anticholinergic, BOTO, Darifenacin, Fesoterodine, Mirabegron, Neurostimulation, Oxybutynin, and Solifenacin. The Anticholinergic is projected to witness significant market share during forecast period.

Based on Disease Type, market is studied across Idiopathic Bladder Overactivity and Neurogenic Bladder Overactivity. The Neurogenic Bladder Overactivity is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Hospital & Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Hospital & Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Overactive Bladder Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Overactive Bladder Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Overactive Bladder Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Overactive Bladder Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Overactive Bladder Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Overactive Bladder Treatment Market?

6. What is the market share of the leading vendors in the Global Overactive Bladder Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Overactive Bladder Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Overactive Bladder Treatment Market, by Drug Therapy, 2022 vs 2030
4.3. Overactive Bladder Treatment Market, by Disease Type, 2022 vs 2030
4.4. Overactive Bladder Treatment Market, by Distribution, 2022 vs 2030
4.5. Overactive Bladder Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growth in number of people with overactive bladder (OAB) symptoms
  - 5.1.1.2. Increase in aging population
- 5.1.2. Restraints
  - 5.1.2.1. Adverse effects and risk associated with overactive bladder treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Overactive bladder clinical research trials and pipeline
- 5.1.4. Challenges
  - 5.1.4.1. Limited awareness of OAB condition
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Overactive Bladder Treatment Market, by Drug Therapy

6.1. Introduction
6.2. Anticholinergic
6.3. BOTO
6.4. Darifenacin
6.5. Fesoterodine
6.6. Mirabegron
6.7. Neurostimulation
6.8. Oxybutynin
6.9. Solifenacin

7. Overactive Bladder Treatment Market, by Disease Type

7.1. Introduction
7.2. Idiopathic Bladder Overactivity
7.3. Neurogenic Bladder Overactivity

8. Overactive Bladder Treatment Market, by Distribution

8.1. Introduction
8.2. Hospital & Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Overactive Bladder Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Overactive Bladder Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Overactive Bladder Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

過活動膀胱治療薬市場：薬物療法、疾患タイプ、流通別-2023-2030年の世界予測

Overactive Bladder Treatment Market by Drug Therapy, Disease Type, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 過活動膀胱治療薬市場薬物療法別

第7章 過活動膀胱治療薬市場：疾患タイプ別

第8章 過活動膀胱治療薬市場配信別

第9章 南北アメリカの過活動膀胱治療薬市場

第10章 アジア太平洋地域の過活動膀胱治療薬市場

第11章 欧州・中東・アフリカの過活動膀胱治療薬市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録